BHC peer analysis
Bausch Health (BHC) against its competitors: price, today's move, 1-year return and market value side by side.
BHC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALVO Alvotech | $4.65 | -4.91% | -40.69% | – |
| ANIP ANI Pharmaceuticals | $70.69 | -1.82% | -23.10% | $1.65B |
| BEAM Beam Therapeutics | $25.86 | -5.03% | 8.66% | $2.81B |
| CON Concentra | $40.33 | -0.12% | 100.85% | – |
| HAE Haemonetics | $120.18 | 0.44% | 140.41% | $5.44B |
| HCM HUTCHMED | $13.15 | -3.24% | -10.61% | $2.29B |
| MLYS Mineralys Therapeutics | $15.52 | -14.63% | -62.26% | – |
| PRGO Perrigo | $15.79 | 0.03% | -23.52% | $2.19B |
| XRAY Dentsply Sirona | $9.89 | 3.78% | -21.45% | $1.90B |
| BHC Bausch Health | $8.03 | -2.07% | 21.48% | $3.07B |
- BHC's peers: ALVO (Alvotech), ANIP (ANI Pharmaceuticals), BEAM (Beam Therapeutics), CON (Concentra), HAE (Haemonetics), HCM (HUTCHMED), MLYS (Mineralys Therapeutics), PRGO (Perrigo).
Updated 2026-11-03 00:02 UTC